Table 2.
All women (n = 21,780) | All men (n = 646,429) | Difference | P value | |
---|---|---|---|---|
LDL < 100 mg/dL | 55 | 68 | 13 | < 0.0001 |
Clinical action measure* | 79 | 85 | 6 | < 0.0001 |
Women with IHD† (n = 3,533) | Men with IHD† (n = 192,038) | Difference | ||
LDL < 100 mg/dL | 67 | 81 | 14 | < 0.0001 |
Clinical action measure* | 84 | 89 | 5 | < 0.0001 |
LDL low-density lipoprotein, IHD ischemic heart disease
*Clinical action measure defined as: LDL < 100 mg/dL; or LDL ≥ 100 mg/dL and the patient was prescribed a moderate or high-dose statin at the time of the test; or index LDL ≥ 100 mg/dL and the patient received other appropriate clinical action within 90 days. Those with no LDL test recorded, but who were prescribed a moderate or high dose statin, also passed the measure on the basis of the prescription. †IHD = ischemic heart disease